Available studies have demonstrated that CCL14 exhibits good diagnostic efficacy for persistent severe AKI (SA-AKI), with the efficacy of urinary CCL14 alone for the prediction of persistent SA-AKI being above 0.80 [19,62], and thus, it is currently recognized as the most effective predictor of persistent severe AKI [20,63]. Here, CCL14 is linked to acute kidney injury.